-
1 Comment
EM Systems Co., Ltd is currently in a long term uptrend where the price is trading 26.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
EM Systems Co., Ltd's total revenue rose by 5.3% to $3B since the same quarter in the previous year.
Its net income has increased by 63.4% to $505M since the same quarter in the previous year.
Based on the above factors, EM Systems Co., Ltd gets an overall score of 4/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| Sector | Healthcare |
| Industry | Health Information Services |
| ISIN | JP3130200003 |
| PE Ratio | 22.48 |
|---|---|
| Target Price | None |
| Dividend Yield | 4.9% |
| Beta | 0.34 |
| Market Cap | 334M |
EM Systems Co., Ltd., together with its subsidiaries, develops and sells various IT systems for pharmacies, clinics, and care/welfare other business in Japan. The company operates through Pharmacy Systems Business, Medical Systems Business, Nursing Care/Welfare System Business, and Other Business segments. It develops and sells IT systems for pharmacies, such as medical fee receipt computers and electronic medication record systems; IT systems for clinics, including medical accounting and electronic medical record systems; and office processing systems for care/welfare providers. In addition, the company offers application service provider Internet based dispensing support system, as well as operates pharmacies; and provides business and management support using statistical information. EM Systems Co., Ltd. was incorporated in 1980 and is headquartered in Osaka, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EMO.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
